Al-Farabi Kazakh National University Report issue

Academic/Hospital Phase 2

Organization Overview

First Clinical Trial
2015
NCT03138785
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Alternative names

Al-Farabi Kazakh National University (KazNU) | Farabi Eye Hospital